Application of RIFLE criteria in patients with multiple myeloma with acute kidney injury: a 15-year retrospective, single center, cohort study

References

• Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med 2004; 351:1860–1873.
   PubMed Web of Science ®Google Scholar
• Rajkumar SV, Kyle RA. Multiple myeloma: diagnosis and treatment. Mayo Clin Proc 2005;80:1371–1382.
   PubMed Web of Science ®Google Scholar
• Jemal A, Murray T, Ward E, et al. Cancer statistics 2005. CA Cancer J Clin 2005;55:10–30.
   PubMed Web of Science ®Google Scholar
• Kyle RA, Therneau TM, Rajkumar SV, et al. Incidence of multiple myeloma in Olmsted County, Minnesota: trend over 6 decades. Cancer 2004;101:2667–2674.
   PubMed Web of Science ®Google Scholar
• Phekoo KJ, Schey SA, Richards MA, et al. A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK. Br J Haematol 2004;127:299–304.
   PubMed Web of Science ®Google Scholar
• Knudsen LM, Hjorth M, Hippe E. Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group. Eur J Haematol 2000;65:175–181.
   PubMed Web of Science ®Google Scholar
• Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003;78:21–33.
   PubMed Web of Science ®Google Scholar
• Bladé J, Fernández-Llama P, Bosch F, et al. Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med 1998;158:1889–1893.
   PubMed Web of Science ®Google Scholar
• Knudsen LM, Hippe E, Hjorth M, et al. Renal function in newly diagnosed multiple myeloma: a demographic study of 1353 patients. The Nordic Myeloma Study Group. Eur J Haematol 1994;53:207–212.
   PubMed Web of Science ®Google Scholar
• Bellomo R, Ronco C, Kellum JA, et al. Acute Dialysis Quality Initiative workgroup: acute renal failure–definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204–R212.
   PubMed Web of Science ®Google Scholar
• Srisawat N, Hoste EE, Kellum JA. Modern classification of acute kidney injury. Blood Purif 2010;29:300–307.
   PubMed Web of Science ®Google Scholar
• Stevens LA, Levey AS. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol 2009;20:2305–2313.
   PubMed Web of Science ®Google Scholar
• Schmitt R, Coca S, Kanbay M, et al CR. Recovery of kidney function after acute kidney injury in the elderly: a systematic review and meta-analysis. Am J Kidney Dis 2008;52:262–271.
   PubMed Web of Science ®Google Scholar
• Irish AB, Winearls CG, Littlewood T. Presentation and survival of patients with severe renal failure and myeloma. QJM 1997;90:773–780.
   PubMed Web of Science ®Google Scholar
• Eleutherakis-Papaiakovou V, Bamias A, Gika D, et al. Greek Myeloma Study Group. Renal failure in multiple myeloma:incidence, correlations, and prognostic significance. Leuk Lymphoma 2007; 48:337–341.
   Google Scholar
• Prakash J, Niwas SS, Parekh A, et al. Multiple myeloma–presenting as acute kidney injury. J Assoc Physicians India 2009;57:23–26.
   PubMedGoogle Scholar
• Haynes RJ, Read S, Collins GP, et al. Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre. Nephrol Dial Transplant 2010;25:419–426.
   PubMed Web of Science ®Google Scholar
• Matsue K, Fujiwara H, Iwama K, et al. Reversal of dialysis-dependent renal failure in patients with advanced multiple myeloma: single institutional experiences over 8 years. Ann Hematol 2010;89: 291–297.
   PubMed Web of Science ®Google Scholar
• Christiansen CF, Johansen MB, Langeberg WJ, et al. Incidence of acute kidney injury in cancer patients: a Danish population-based cohort study. Eur J Intern Med 2011;22:399–406.
   PubMed Web of Science ®Google Scholar
• U. S. Renal Data System, USRDS 2010 annual data report: Atlas of chronic kidney disease and end stage renal disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health; 2010.
   Google Scholar
• Kellum JA, Levin N, Bouman C, et al. Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 2002;8:509–514.
   PubMedGoogle Scholar
• Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16:3365–3370.
   PubMed Web of Science ®Google Scholar
• Kellum JA, Bellomo R, Ronco C. Classification of acute kidney injury using RIFLE: what's the purpose?Crit Care Med 2007;35: 1983–1984.
   PubMed Web of Science ®Google Scholar
• Ricci Z, Cruz DN, Ronco C. The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int 2008;73:538–546.
   PubMed Web of Science ®Google Scholar
• Bagshaw SM, George C, Dinu I, et al. A Multi-center evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008;23:1203–1210.
   PubMed Web of Science ®Google Scholar
• Thakar CV, Christianson A, Freyberg R, et al. Incidence and outcomes of acute kidney injury in intensive care units: a Veterans Administration study. Crit Care Med 2009;37:2552–2558.
   PubMed Web of Science ®Google Scholar
• Dimopoulos MA, Terpos E, Chanan-Khan A, et al. Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group. J Clin Oncol 2010;28:4976–4984.
   PubMed Web of Science ®Google Scholar
• Cruz DN, Ricci Z, Ronco C. Clinical review: RIFLE and AKIN–time for reappraisal. Crit Care 2009;13:211.
   PubMed Web of Science ®Google Scholar
• Ronco PM, Aucouturier P, Mougenot B. Monoclonal gammopathies: multiple myeloma, amyloidosis and related disorders. In: Schrier RW, editor. Diseases of the kidney and urinary tract. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001. pp 2205–2254.
   Google Scholar
• Chanan-Khan AA, Kaufman JL, Mehta J, et al. Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study. Blood 2007;109: 2604–2606.
   PubMed Web of Science ®Google Scholar
• Roussou M, Kastritis E, Christoulas D, et al. Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents. Leuk Res 2010;34:1395–1397.
   PubMed Web of Science ®Google Scholar
• Johnson WJ, Kyle RA, Pineda AA, et al. Treatment of renal failure associated with multiple myeloma: plasmapheresis, hemodialysis and chemotherapy. Arch Intern Med 1990;150:863–869.
   PubMed Web of Science ®Google Scholar
• Zucchelli P, Pasquali S, Cagnoli L, et al. Controlled plasma exchange trial in acute renal failure due to multiple myeloma. Kidney Int 1988;33:1175–1180.
   PubMed Web of Science ®Google Scholar
• Clark WF, Stewart AK, Rock GA, et al. Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial. Ann Intern Med 2005;143:777–784.
   PubMed Web of Science ®Google Scholar
• Hutchison CA, Cockwell P, Reid S, et al. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies. J Am Soc Nephrol 2007;18: 886–895.
   PubMed Web of Science ®Google Scholar
• Bridoux F, Fermand JP. Optimizing treatment strategies in myeloma cast nephropathy: rationale for a randomized prospective trial. Adv Chronic Kidney Dis 2012;19:333–341.
   PubMed Web of Science ®Google Scholar
• Oyajobi BO. Multiple myeloma/hypercalcemia. Arthritis Res Ther 2007;9(Suppl. 1):S4.
   Web of Science ®Google Scholar